MRUS Advances Cancer Therapy, DUOT Optimizes Rail Inspection with AI

Merus N.V. (MRUS)

Merus N.V. is a clinical-stage oncology company focused on developing innovative bispecific antibody therapies for cancer treatment. Its proprietary Biclonics® platform is designed to address unmet medical needs in solid tumors and blood cancers. Key drivers include pipeline progress, clinical trial data, and partnerships. Chart

Duos Technologies Group, Inc. (DUOT)

Duos Technologies provides intelligent security and automation systems for critical infrastructure. Its solutions use AI and machine vision for real-time inspection, primarily in rail and transportation. Growth is driven by increased infrastructure investments and demand for advanced monitoring tech. Chart

Trending Ideas

Featured Stocks On The Move